These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 32926272)

  • 101. Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA).
    Cenko E; Badimon L; Bugiardini R; Claeys MJ; De Luca G; de Wit C; Derumeaux G; Dorobantu M; Duncker DJ; Eringa EC; Gorog DA; Hassager C; Heinzel FR; Huber K; Manfrini O; Milicic D; Oikonomou E; Padro T; Trifunovic-Zamaklar D; Vasiljevic-Pokrajcic Z; Vavlukis M; Vilahur G; Tousoulis D
    Cardiovasc Res; 2021 Dec; 117(14):2705-2729. PubMed ID: 34528075
    [TBL] [Abstract][Full Text] [Related]  

  • 102. SARS-CoV-2: basic concepts, origin and treatment advances.
    Santos-López G; Cortés-Hernández P; Vallejo-Ruiz V; Reyes-Leyva J
    Gac Med Mex; 2021; 157(1):84-89. PubMed ID: 34125824
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Neurological infection and complications of SARS-CoV-2: A review.
    Singh S; Meher N; Mohammed A; Razab MKAA; Bhaskar LVKS; Nawi NM
    Medicine (Baltimore); 2023 Feb; 102(5):e30284. PubMed ID: 36749239
    [TBL] [Abstract][Full Text] [Related]  

  • 104. The Importance of Understanding the Stages of COVID-19 in Treatment and Trials.
    Griffin DO; Brennan-Rieder D; Ngo B; Kory P; Confalonieri M; Shapiro L; Iglesias J; Dube M; Nanda N; In GK; Arkfeld D; Chaudhary P; Campese VM; Hanna DL; Sawcer D; Ehresmann G; Peng D; Smorgorzewski M; Amstrong A; Vinjevoll EH; Dasgupta R; Sattler FR; Mussini C; Mitjà O; Soriano V; Peschanski N; Hayem G; Piccirillo MC; Lobo-Ferreira A; Rivero IB; Hung IFH; Rendell M; Ditmore S; Varon J; Marik P
    AIDS Rev; 2021 Feb; 23(1):40-47. PubMed ID: 33556957
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Molecular chronicles of cytokine burst in patients with coronavirus disease 2019 (COVID-19) with cardiovascular diseases.
    Thankam FG; Agrawal DK
    J Thorac Cardiovasc Surg; 2021 Feb; 161(2):e217-e226. PubMed ID: 32631657
    [No Abstract]   [Full Text] [Related]  

  • 106. Cardiovascular manifestations secondary to COVID-19: A narrative review.
    Fauvel C; Trimaille A; Weizman O; Pezel T; Mika D; Waldmann V; Cohen A; Bonnet G
    Respir Med Res; 2022 May; 81():100904. PubMed ID: 35525097
    [TBL] [Abstract][Full Text] [Related]  

  • 107. The impact of SARS-CoV-2 treatment on the cardiovascular system: an updated review.
    Akkaif MA; Sha'aban A; Cesaro A; Jaber AAS; Vergara A; Yunusa I; Jatau AI; Mohammed M; Govindasamy GS; Al-Mansoub MA; Sheikh Abdul Kader MA; Ibrahim B
    Inflammopharmacology; 2022 Aug; 30(4):1143-1151. PubMed ID: 35701719
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Liver injury in the era of COVID-19.
    Cichoż-Lach H; Michalak A
    World J Gastroenterol; 2021 Feb; 27(5):377-390. PubMed ID: 33584070
    [TBL] [Abstract][Full Text] [Related]  

  • 109. COVID-19's immuno-pathology and cardiovascular diseases.
    Nasab EM; Aghajani H; Makoei RH; Athari SS
    J Investig Med; 2023 Feb; 71(2):71-80. PubMed ID: 36647329
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Can Selenium Reduce the Susceptibility and Severity of SARS-CoV-2?-A Comprehensive Review.
    Majeed M; Nagabhushanam K; Prakasan P; Mundkur L
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563199
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Pathophysiology and pharmacological management of pulmonary and cardiovascular features of COVID-19.
    Hamouche W; Bisserier M; Brojakowska A; Eskandari A; Fish K; Goukassian DA; Hadri L
    J Mol Cell Cardiol; 2021 Apr; 153():72-85. PubMed ID: 33373644
    [TBL] [Abstract][Full Text] [Related]  

  • 112. The potential role of thymoquinone in preventing the cardiovascular complications of COVID-19.
    Ahmad A; Raish M; Alkharfy KM
    Vascul Pharmacol; 2021 Dec; 141():106899. PubMed ID: 34311073
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Unraveling the mystery of Covid-19 cytokine storm: From skin to organ systems.
    Garg S; Garg M; Prabhakar N; Malhotra P; Agarwal R
    Dermatol Ther; 2020 Nov; 33(6):e13859. PubMed ID: 32559324
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Can Epigenetics Help Solve the Puzzle Between Concomitant Cardiovascular Injury and Severity of Coronavirus Disease 2019?
    Braga CL; Acquarone M; Arona VDC; Osório BS; Barreto TG; Kian RM; Pereira JPAL; Silva MMCD; Silva BA; de Oliveira GMM; Macedo Rocco PR; Silva PL; Alencar AKN
    J Cardiovasc Pharmacol; 2022 Apr; 79(4):431-443. PubMed ID: 34935698
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Cardiovascular Dysfunction in COVID-19: Association Between Endothelial Cell Injury and Lactate.
    Yang K; Holt M; Fan M; Lam V; Yang Y; Ha T; Williams DL; Li C; Wang X
    Front Immunol; 2022; 13():868679. PubMed ID: 35401579
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Cardiac complications of COVID-19 infection.
    Randhawa S; Alsamarrai AJ; Lee S; Somaratne JB
    N Z Med J; 2023 Mar; 136(1571):73-82. PubMed ID: 36893397
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Intricate interplay between Covid-19 and cardiovascular diseases.
    Keri VC; Hooda A; Kodan P; R L B; Jorwal P; Wig N
    Rev Med Virol; 2021 Jul; 31(4):e2188. PubMed ID: 33128859
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Role of Resveratrol in Prevention and Control of Cardiovascular Disorders and Cardiovascular Complications Related to COVID-19 Disease: Mode of Action and Approaches Explored to Increase Its Bioavailability.
    Gligorijević N; Stanić-Vučinić D; Radomirović M; Stojadinović M; Khulal U; Nedić O; Ćirković Veličković T
    Molecules; 2021 May; 26(10):. PubMed ID: 34064568
    [TBL] [Abstract][Full Text] [Related]  

  • 119. COVID-19 and cardiovascular complications: an update from the underlying mechanism to consequences and possible clinical intervention.
    Iqubal A; Iqubal MK; Hoda F; Najmi AK; Haque SE
    Expert Rev Anti Infect Ther; 2021 Sep; 19(9):1083-1092. PubMed ID: 33618607
    [No Abstract]   [Full Text] [Related]  

  • 120. Acute Cardiovascular Complications of COVID-19: The High Risk of Underlying Heart Disease.
    Mensah GA; Vaduganathan M; Roth GA
    J Am Coll Cardiol; 2023 Feb; 81(6):570-573. PubMed ID: 36754517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.